HRTX - Heron: What's In Store For The Regulatory Binary Of HTX-011?
We select such investments on a long-term basis, weighing the same factors as would be involved in the purchase of 100% of an operating business: (1) favorable long-term economic characteristics; (2) competent and honest management; (3) purchase price attractive when measured against the yardstick of value to a private owner; and (4) an industry with which we are familiar and whose long-term business characteristics we feel competent to judge. - Warren Buffett
Since Integrated BioSci Investing commenced in 2017, I noticed that many gene therapy innovators received significant success due to both market "popularity" and